Current Value of Holding

$580 Million

Shares

5.37 Million

% of Portfolio

0.57%

Average Buy Price

$74.7

Avg closing price
Price range

47 Ken Griffin Gilead Sciences Trades

Ken Griffin acquired 1.23 Million Gilead Sciences shares worth $133 Million. That's 0.13% of their equity portfolio (188th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Ken Griffin bought shares 57 more times and sold shares on 57 occasions. The stake costed the investor $88.9 Million, netting the investor a gain of 50% so far.

Avg closing price
Price range
Increased shares by 14.4% (+678 Thousand shares) Q1 2025
Avg closing price $102.80
Price range $89.14 - $117.41
Sold 6.4% shares (-322 Thousand shares) Q4 2024
Avg closing price $90.22
Price range $83.94 - $97.90
Increased shares by 1702.5% (+4.74 Million shares) Q3 2024
Avg closing price $76.20
Price range $66.59 - $83.99
Sold 94.8% shares (-5.04 Million shares) Q2 2024
Avg closing price $66.73
Price range $63.15 - $72.88
Increased shares by 1226.4% (+4.92 Million shares) Q1 2024
Avg closing price $76.90
Price range $71.58 - $87.29
Increased shares by 2.4% (+9.29 Thousand shares) Q4 2023
Avg closing price $77.82
Price range $73.27 - $83.09
Increased shares by 31.1% (+93.1 Thousand shares) Q3 2023
Avg closing price $76.92
Price range $73.94 - $80.67
Sold 86.7% shares (-1.95 Million shares) Q2 2023
Avg closing price $79.75
Price range $76.01 - $86.70
Increased shares by 36.1% (+597 Thousand shares) Q1 2023
Avg closing price $82.82
Price range $77.31 - $88.08
Increased shares by 384.7% (+1.31 Million shares) Q4 2022
Avg closing price $79.19
Price range $62.32 - $89.47
Sold 89.1% shares (-2.79 Million shares) Q3 2022
Avg closing price $63.06
Price range $59.54 - $68.01
Increased shares by 27.7% (+677 Thousand shares) Q2 2022
Avg closing price $61.91
Price range $57.72 - $65.01
Increased shares by 268.7% (+1.79 Million shares) Q1 2022
Avg closing price $63.92
Price range $57.92 - $72.58
Increased shares by 67.6% (+268 Thousand shares) Q4 2021
Avg closing price $68.88
Price range $64.88 - $73.64
Sold 65.7% shares (-759 Thousand shares) Q3 2021
Avg closing price $70.25
Price range $67.69 - $73.03
Sold 81.1% shares (-4.97 Million shares) Q2 2021
Avg closing price $66.77
Price range $63.47 - $69.35
Increased shares by 115.7% (+3.29 Million shares) Q1 2021
Avg closing price $64.48
Price range $60.00 - $68.46
Increased shares by 56.3% (+1.02 Million shares) Q3 2020
Avg closing price $69.35
Price range $62.10 - $78.08
Increased shares by 223.8% (+1.26 Million shares) Q2 2020
Avg closing price $76.64
Price range $72.34 - $84.00
Sold 58.6% shares (-795 Thousand shares) Q1 2020
Avg closing price $69.10
Price range $62.63 - $80.22

News about Gilead Sciences, Inc. and Ken Griffin

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!